
Atsena Therapeutics
Developer of ocular gene therapies designed to reverse or prevent blindness. The company's programs include treatments for leading forms of Leber congenital amaurosis and Usher syndrome and have a pip...
Valuation
$340M
Latest known
Share Price
N/A
Total Raised
$237.7M
Last Round
N/A